Pronađeno: 1-4 / 4 radova

Autori: Bondarenko Igor N

>> Filter: Samo Article i Review

>> Sve godine

Naslov Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. (Meeting Abstract)
Autori Trukhin Dmytro Poddubskaya Elena Andric Zoran G  Bondarenko Igor N Shevnia Serhii Zaric Bojan  Bellala Ravishankar Charoentum Chaiyut Perez Luis Bullo Felicitas Garcia Fernanda 
Info JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. -
Projekat mAbxience Research
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article)
Autori Syrigos Konstantinos Abert Istvan Andric Zoran G  Bondarenko Igor N Dvorkin Mikhail Galic Kristina Galiulin Rinat Kuchava Vladimer Sriuranpong Virote Trukhin Dmytro Zhavrid Edvard Fu Dongyue Kassalow Laurent M Jones Stephanie Bashir Zahid 
Info BIODRUGS, (2021), vol. 35 br. 4, str. 417-428
Projekat Centus Biotherapeutics
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study. (Meeting Abstract)
Autori Millan Susana Trukhin Dmytro Kolesnik Oleksii Poddubskaya Elena Andric Zoran G  Bondarenko Igor N Shevnia Serhii Bullo Felicitas Sarnago Cristina 
Info JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 15, Suppl. S, str. -
Projekat mAbxience Research SI
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract)
Autori Fennell DA Goss GD Andric Zoran G  Bondarenko Igor N Zaric Bojan  Ceric Timur Poddubskaya Elena Teofilovici F Guo W Ramalingam Suresh S 
Info EUROPEAN JOURNAL OF CANCER, (2013), vol. 49 br. , Suppl. 2, str. S801-S801
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX